Guilin Sanjin Pharmaceutical (002275.SZ) announced on June 3rd that as of June 1st, 2024, more than half of the shareholding plan had passed. Mr. Zou Xun, the actual controller, chairman and CEO of the company, has accumulated 148,300 shares of the company's stock through centralized bidding on the Shenzhen Stock Exchange, accounting for 0.03% of the company's existing total share capital. The total amount of shareholding is 2.0472 million yuan.
桂林三金(002275.SZ)：实控人邹洵增持期过半 累计增持14.83万股
Guilin Sanjin Pharmaceutical (002275.SZ): The actual controller Zou Xun has passed the halfway mark of the shareholding period and has accumulated 148,300 shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.